We have detected you are using a machine at UQ and you do not currently have an active Internet Session. Any externally hosted content will not appear unless you have an active Internet session. Please create an Internet session by going to https://login.uq.edu.au

Delivery of Drugs and Genes Group: Fundamental research and applied techniques for needle-free vaccination delivery systems

D2G2's foremost development is the Nanopatch developed at the Australian Institute for Bioengineering and Nanotechnology (AIBN). The ultimate goal of our research is to dramatically improve the cost and efficiency of vaccination and treatment of major diseases.

Learn more about our research
Read about our publications
Meet Mark Kendall and the D2G2 Team

Delivery of Drugs and Genes Group Professor Mark Kendall

The D2G2 Group, led by Professor Mark Kendall, focuses on fundamental research and applied techniques for needle-free vaccination delivery systems.

One of our foremost developments is the Nanopatch developed at the Australian Institute for Bioengineering & Nanotechnology (AIBN).

Mark Kendall
Group Leader